Cardinal Health, Inc.

New York Stock Exchange
Back to all articles
Somewhat Bullish +35

Bleakley Financial Group LLC Invests $4.36 Million in Cardinal Health ...

AI-generated analysis

📈 Bleakley Financial Group LLC acquired a new position in Cardinal Health valued at approximately $4.36 million during the first quarter.

📉 Jones Financial Companies Lllp lifted its position by 198.3%, now holding 21,112 shares valued at $27,000.

📊 Cardinal Health reported Q1 EPS of $3.17, surpassing analyst consensus estimates of $2.79.

💰 The company generated revenue of $60.94 billion for the quarter, representing an 11% year-over-year increase.

📉 Revenue missed analyst expectations of $62.10 billion by approximately $1.16 billion.

📈 TD Cowen raised its price target to $275 and maintained a 'buy' rating on the stock.

📉 Evercore decreased its price target from $260 to $240 while maintaining an 'outperform' rating.

💵 Cardinal Health increased its quarterly dividend to $0.5158, resulting in an annualized yield of 0.9%.

🎯 The consensus analyst price target for the stock is currently set at $249.13.

📉 Wells Fargo lowered its price target to $245 but retained an 'overweight' rating.

🏢 Cardinal Health operates as a major provider of supply chain and distribution services for the healthcare sector.

📈 Institutional investors own 87.17% of the company's outstanding stock.

Bullish Signals
  • Cardinal Health reported Q1 earnings per share of $3.17, which beat analyst consensus estimates of $2.79 by $0.38.
  • The company achieved a significant 11% year-over-year revenue growth, reaching $60.94 billion for the quarter.
  • TD Cowen increased its price objective to $275 and issued a 'buy' rating on the stock.
  • Citigroup reissued a 'buy' rating on Cardinal Health shares in a recent research report.
  • The company recently increased its quarterly dividend from $0.51 to $0.5158 per share.
  • Jones Financial Companies Lllp significantly increased its stake by 198.3% during the first quarter.
  • Bleakley Financial Group LLC established a new position valued at approximately $4.36 million in the company.
Risk Factors
  • Cardinal Health's Q1 revenue of $60.94 billion missed analyst consensus estimates of $62.10 billion.
  • Evercore decreased its price target on Cardinal Health from $260.00 to $240.00 in a recent report.
  • Wells Fargo & Company lowered its price target on the stock from $256.00 to $245.00.
  • The company reported a negative return on equity of 92.61% for the quarter.
Full Analysis
Bleakley Financial Group LLC acquired a new position in Cardinal Health, Inc. (NYSE:CAH) during the first quarter, purchasing 20,619 shares valued at approximately $4.36 million. Other institutional investors, including Aventura Private Wealth and University of Texas Investment Management, also established or increased stakes, while Jones Financial Companies significantly lifted its position by 198.3%. Institutional ownership remains high at 87.17%, indicating continued interest from major funds. Analyst sentiment regarding Cardinal Health is mixed but generally positive, with a consensus rating of 'Moderate Buy' and an average price target of $249.13. While Evercore and Wells Fargo recently lowered their price targets to $240 and $245 respectively, TD Cowen raised its objective to $275 with a 'buy' rating, and Citigroup reissued a 'buy'. The stock currently trades at a PE ratio of 34.37 with a market capitalization of $52.64 billion. Financially, Cardinal Health reported Q1 earnings of $3.17 per share, beating analyst estimates of $2.79, though revenue of $60.94 billion missed expectations at $62.10 billion. Revenue grew 11% year-over-year to $60.94 billion. The company recently increased its quarterly dividend to $0.5158 per share, representing a yield of 0.9% and a payout ratio of 31.50%. FY 2026 guidance stands between $10.70 and $10.80 EPS.